Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

by Riddle, Matthew C , Inzucchi, Silvio E , Cannon, Christopher P , Cherney, David Z.I , Bhatt, Deepak L , Szarek, Michael , Bailey, Clifford J , Lopes, Renato D , Díaz, Rafael , Ray, Kausik K , Leiter, Lawrence A , Scirica, Benjamin M , Udell, Jacob A , Steg, P. Gabriel , Lewis, Julia B , McGuire, Darren K , Lapuerta, Pablo , Kosiborod, Mikhail N , Pitt, Bertram , Dwyer, Jamie P

in Adverse events / Aged / Cardiovascular diseases / Cardiovascular Diseases - epidemiology / Cardiovascular Diseases - mortality / Cerebral infarction / Confidence intervals / Congestive heart failure / Corporate sponsorship / Creatinine / Diabetes / Diabetes mellitus (non-insulin dependent) / Diabetes Mellitus, Type 2 - complications / Diabetes Mellitus, Type 2 - drug therapy / Diabetic ketoacidosis / Diabetic Ketoacidosis - chemically induced / Diarrhea / Diarrhea - chemically induced / Double-Blind Method / Female / Glomerular filtration rate / Glucose / Glycosides - adverse effects / Glycosides - therapeutic use / Heart attacks / Heart failure / Hemoglobin / Hospitalization / Hospitalization - statistics & numerical data / Humans / Ketoacidosis / Kidney diseases / Male / Middle Aged / Mycoses - etiology / Myocardial infarction / Patients / Placebos / Renal Insufficiency, Chronic - complications / Renal Insufficiency, Chronic - drug therapy / Risk factors / Sodium-glucose cotransporter / Sodium-Glucose Transporter 1 - antagonists & inhibitors / Sodium-Glucose Transporter 2 Inhibitors - adverse effects / Sodium-Glucose Transporter 2 Inhibitors - therapeutic use / Statistical analysis

2021

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

2021

Confirm

Do you wish to request the book?

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

2021

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

Riddle, Matthew C,

Inzucchi, Silvio E,

Cannon, Christopher P,

Cherney, David Z.I,

Bhatt, Deepak L,

Szarek, Michael,

Bailey, Clifford J,

Lopes, Renato D,

Díaz, Rafael,

Ray, Kausik K,

Leiter, Lawrence A,

Scirica, Benjamin M,

Udell, Jacob A,

Steg, P. Gabriel,

Lewis, Julia B,

McGuire, Darren K,

Lapuerta, Pablo,

Kosiborod, Mikhail N,

Pitt, Bertram,

Dwyer, Jamie P

2021

Overview

In a trial involving 10,584 patients with diabetes and chronic kidney disease, sotagliflozin resulted in fewer total deaths from cardiovascular causes, hospitalizations for heart failure, and urgent visits for heart failure than placebo. Diarrhea, mycotic infections, and diabetic ketoacidosis occurred with sotagliflozin.

Share this book

Add to My Shelf

Publisher

Massachusetts Medical Society

Subject

Adverse events

/ Aged

/ Cardiovascular diseases

/ Cardiovascular Diseases - epidemiology

/ Cardiovascular Diseases - mortality

/ Cerebral infarction

/ Confidence intervals